We found that 3,730 genes including lung adenocarcinoma biomarkers NPC2 (33) and NAPSA (34) were differentially expressed between normal lung (n = 11) and post-treatment tumor (n = 11) (Supplementary Table S5 and Supplementary Figure S4A). The gene discussed is NPC2; the disease is lung adenocarcinoma.